Who are Daré Bioscience, Inc.'s main suppliers?

Daré Bioscience, Inc. (DARE) key suppliers include: SECTION-503B-REGISTERED-OUTSOURCING-FACILITIES, ORANY, ORANY, XOMA Royalty Corporation. View the full supplier network at chainsifter.com/chain/DARE.

Who are Daré Bioscience, Inc.'s major customers?

Daré Bioscience, Inc. (DARE) key customers include: GATES-FOUNDATION, ORANY, ORANY, CAPITAL-RESOURCES, DARE-MB-INC. View the full customer network at chainsifter.com/chain/DARE.

What sector is Daré Bioscience, Inc. in?

Daré Bioscience, Inc. (DARE) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

Daré Bioscience, Inc. Supplier List (DARE): 4 Verified Suppliers

4Suppliers

5Customers

3Debt Items

20Related Chains

Source-Backed Evidence Depth

Daré Bioscience, Inc. (DARE) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

13Total relationships

2Distinct source URLs

6High confidence

0.789Average confidence

2026-09-13Latest database update

ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Daré Bioscience, Inc. Suppliers

Ticker	Name	Confidence	Evidence
SECTION-503B-REGISTERED-OUTSOURCING-FACILITIES	SECTION-503B-REGISTERED-OUTSOURCING-FACILITIES	90%	the Company makes unsecured advances to certain suppliers, specifically, the Section 503B-registered outsourcing facilities engaged to manufacture and distribute the Company's Section 503B products
ORANY	ORANY	72%	her material deficiency is found. The FDA requires that certain classifications of recalls be reported to the FDA within ten working days after the recall is initiated. As with prescription drugs, th…
ORANY	ORANY	72%	Reciprocal relationship from ORANY graph: Reciprocal relationship from DARE graph: her material deficiency is found. The FDA requires that certain classifications of recalls be reported to the FDA wi…
XOMA	XOMA Royalty Corporation	72%	Reciprocal relationship from XOMA graph: Item 4. Mine Safety Disclosures 70 Item 5. Other Information 70 Item 6. Exhibits 71 Signatures 74 2 Table of…

Daré Bioscience, Inc. Customers

Ticker	Name	Confidence	Evidence
GATES-FOUNDATION	GATES-FOUNDATION	92%	The Foundation Services Agreements are accounted for as contracts with a customer under FASB Accounting Standards Codification (ASC) 606, as each represents an exchange transaction in which the Found…
ORANY	ORANY	72%	her material deficiency is found. The FDA requires that certain classifications of recalls be reported to the FDA within ten working days after the recall is initiated. As with prescription drugs, th…
ORANY	ORANY	72%	Reciprocal relationship from ORANY graph: Reciprocal relationship from DARE graph: Reciprocal relationship from ORANY graph: Reciprocal relationship from DARE graph: her material deficiency is found.…
CAPITAL-RESOURCES	CAPITAL-RESOURCES	62%	consolidated financial statements, refer to Item 7 in Management’s Discussion and Analysis of Financial Condition and Results of Operations in our 2025 10-K. Since December 31, 2025, there have been …
DARE-MB-INC	DARE-MB-INC	62%	. The Foundation Services Agreements are accounted for as contracts with a customer under FASB Accounting Standards Codification ("ASC") 606, as each represents an exchange transaction in which the F…

Daré Bioscience, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
DARE-DEBT-9017	Warrants outstanding: 265485	90%	xbrl warrant detail from xbrl 2023-12-31.
DARE-DEBT-9018	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2018-12-31.
DARE-DEBT	Debt stack $10,542	90%	Market cache reports total debt of $10,542.

Daré Bioscience, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Daré Bioscience, Inc..

Daré Bioscience, Inc. Ownership

Holder	Name	Confidence	Evidence
DARE-OWNER-VANGUARD-CAPITAL-MANAGEMENT-LLC	VANGUARD CAPITAL MANAGEMENT LLC	90%	13F overlay lists VANGUARD CAPITAL MANAGEMENT LLC as top holder; 26 tracked holders.

Daré Bioscience, Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
XOMA	XOMA Royalty Corporation	100.00	1	['supplier']
ORANY	ORANGE	100.00	1	['customer', 'supplier']
AMZE	Amaze Holdings, Inc.	50.00	2
AYTU	Aytu BioPharma, Inc.	50.00	2
CYCN	Cyclerion Therapeutics, Inc.	50.00	2
D	Dominion Energy, Inc.	50.00	2
DFTX	Definium Therapeutics, Inc.	50.00	2
ED	Consolidated Edison, Inc.	50.00	2
CHUC	Charlie's Holdings, Inc.	50.00	2
CLNE	Clean Energy Fuels Corp.	50.00	2
FENC	Fennec Pharmaceuticals Inc.	50.00	2
EQR	Equity Residential	50.00	2
CNOB	ConnectOne Bancorp, Inc.	50.00	2
DWTX	Dogwood Therapeutics, Inc.	50.00	2
ESS	Essex Property Trust, Inc.	50.00	2
CANF	Can-Fite BioPharma Ltd.	50.00	2
CORT	Corcept Therapeutics Incorporated	50.00	2
LGND	Ligand Pharmaceuticals Incorporated	50.00	2
BSBK	Bogota Financial Corp.	50.00	2
CPRX	Catalyst Pharmaceuticals, Inc.	50.00	2

Daré Bioscience, Inc. Supply Chain